Step Pharma Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Later Stage VC
  • (In Progress)

  • Latest Deal Amount
  • $10M

  • Investors
  • 13

Step Pharma General Information

Description

Developer of proprietary small molecule therapeutics designed for the treatment of autoimmune diseases. The company's therapeutics use a novel class of oral nucleotide synthesis inhibitors that can target CTPS1 (cytidine triphosphate synthase 1) to induce selective modulation of specific immune cell populations such as T and B cells, translating to better efficacy and an improved therapeutic index, enabling healthcare providers to properly treat autoimmune diseases.

Contact Information

Website
www.step-ph.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 15 Rue Louis and Auguste Lumière
  • Technoparc du Pays-de-Gex
  • 01630 Saint-Genis-Pouilly
  • France
+33 01
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 15 Rue Louis and Auguste Lumière
  • Technoparc du Pays-de-Gex
  • 01630 Saint-Genis-Pouilly
  • France
+33 01

Step Pharma Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Step Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC 19-Feb-2026 $10M In Progress Clinical Trials - Phase 1
12. Accelerator/Incubator 19-Feb-2026 Completed Clinical Trials - Phase 1
11. Accelerator/Incubator 01-Jan-2026 Completed Clinical Trials - Phase 1
10. Later Stage VC (Series C) 15-Oct-2025 Completed Clinical Trials - Phase 1
9. Accelerator/Incubator 01-Jan-2024 Completed Clinical Trials - Phase 1
8. Secondary Transaction - Private 01-Jul-2021 Completed Pre-Clinical Trials
7. Later Stage VC (Series B) 24-Mar-2021 Completed Pre-Clinical Trials
6. Early Stage VC 16-Dec-2018 Completed Pre-Clinical Trials
5. Early Stage VC (Series A) 21-Nov-2017 $16.9M $21.2M Completed Startup
4. Early Stage VC 28-Jul-2015 $830K $4.22M Completed Startup
To view Step Pharma’s complete valuation and funding history, request access »

Step Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C shares
BSA-T4
BSA-T3
BSA-T2
ADP B
Category B Preference
Ordinary
Series A
Series A 2,935,873 $0.117118 $2.34 $2.34 1x $2.34 7.05%
Ordinary 1,250,000 $0.117118 $2.34 $2.34 1x $2.34 3%
To view Step Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Step Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of proprietary small molecule therapeutics designed for the treatment of autoimmune diseases. The company's th
Drug Discovery
Saint-Genis-Pouilly, France
12 As of 2021

Santa Monica, CA
 

Pittsburgh, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Step Pharma Competitors (47)

One of Step Pharma’s 47 competitors is Kite Pharma, a Formerly VC-backed company based in Santa Monica, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kite Pharma Formerly VC-backed Santa Monica, CA
Noveome Biotherapeutics Venture Capital-Backed Pittsburgh, PA
Carisma Therapeutics Formerly VC-backed Philadelphia, PA
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Adimab Venture Capital-Backed Lebanon, NH
You’re viewing 5 of 47 competitors. Get the full list »

Step Pharma Patents

Step Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026027753-A1 Ctps1 inhibitors for the treatment of myeloproliferative neoplasms Pending 02-Aug-2024
WO-2024133721-A1 Combinations of ctps1 inhibitor with iap inhibitor for use in the treatment of cancer Inactive 21-Dec-2022
AU-2023411337-A1 Ctps1 inhibitors for use in the treatment of ctps2 deficient cancer Pending 21-Dec-2022
EP-4637770-A1 Ctps1 inhibitors for use in the treatment of ctps2 deficient cancer Pending 21-Dec-2022
US-20260207590-A1 Ctps1 inhibitors for use in the treatment of ctps2 deficient cancer Pending 21-Dec-2022 A61K31/506
To view Step Pharma’s complete patent history, request access »

Step Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Step Pharma Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Accelerator/Incubator Minority
La French Tech Accelerator/Incubator
InnoBiologics Venture Capital Minority
V-Bio Ventures Venture Capital Minority
Matwin Accelerator/Incubator
You’re viewing 5 of 13 investors. Get the full list »

Step Pharma FAQs

  • When was Step Pharma founded?

    Step Pharma was founded in 2014.

  • Where is Step Pharma headquartered?

    Step Pharma is headquartered in Saint-Genis-Pouilly, France.

  • What is the size of Step Pharma?

    Step Pharma has 12 total employees.

  • What industry is Step Pharma in?

    Step Pharma’s primary industry is Drug Discovery.

  • Is Step Pharma a private or public company?

    Step Pharma is a Private company.

  • What is Step Pharma’s current revenue?

    The current revenue for Step Pharma is .

  • How much funding has Step Pharma raised over time?

    Step Pharma has raised $115M.

  • Who are Step Pharma’s investors?

    European Innovation Council, La French Tech, InnoBiologics, V-Bio Ventures, and Matwin are 5 of 13 investors who have invested in Step Pharma.

  • Who are Step Pharma’s competitors?

    Kite Pharma, Noveome Biotherapeutics, Carisma Therapeutics, Adaptimmune Therapeutics, and Adimab are some of the 47 competitors of Step Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process